303 related articles for article (PubMed ID: 17117660)
1. [Can higher level of HDL cholesterol augment cardiovascular disease prevention? The combination statins-nicotinic acid increases the level of HDL and reduces the level of LDL cholesterol].
Carlson LA
Lakartidningen; 2006 Oct 25-31; 103(43):3283-5. PubMed ID: 17117660
[No Abstract] [Full Text] [Related]
2. [Considerable remaining risk in unchecked LDL lowering. Is the HDL increase the way out?].
MMW Fortschr Med; 2006 Jun; 148(24):6, 8. PubMed ID: 16856232
[No Abstract] [Full Text] [Related]
3. [Safety and tolerability of nicotinic acid. Results of the multicenter, open, prospective NAUTILUS study].
Vogt A; Kassner U; Hostalek U; Peiter A; Steinhagen-Thiessen E
MMW Fortschr Med; 2006 May; 148(18):41. PubMed ID: 16736688
[No Abstract] [Full Text] [Related]
4. Nicotinic acid, alone and in combinations, for reduction of cardiovascular risk.
Brown BG; Zhao XQ
Am J Cardiol; 2008 Apr; 101(8A):58B-62B. PubMed ID: 18375243
[TBL] [Abstract][Full Text] [Related]
5. [LDL lowering--level and time. Maybe two equally important parameters for protection against arteriosclerosis].
Herlitz J
Lakartidningen; 2006 Oct 25-31; 103(43):3272-3. PubMed ID: 17117658
[No Abstract] [Full Text] [Related]
6. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
Hausenloy DJ; Yellon DM
Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
[TBL] [Abstract][Full Text] [Related]
7. Statins. Cholesterol treatment and beyond.
Mayo Clin Health Lett; 2004 Nov; 22(11):1-3. PubMed ID: 15619748
[No Abstract] [Full Text] [Related]
8. Treatment of high-risk older persons with lipid-lowering drug therapy.
Aronow WS
Am J Ther; 2008; 15(2):102-7. PubMed ID: 18356628
[TBL] [Abstract][Full Text] [Related]
9. Focus on HDL as a therapeutic target for CAD risk reduction.
Davidson MH
Am J Cardiol; 2009 Nov; 104(10 Suppl):1E-2E. PubMed ID: 19895937
[No Abstract] [Full Text] [Related]
10. [Strengthened support for statin therapy as secondary prevention. Doubtful evidence for more intensive lowering of cholesterol levels].
HÃ¥kansson J
Lakartidningen; 2011 Jun 1-14; 108(22-23):1234-5. PubMed ID: 21786497
[No Abstract] [Full Text] [Related]
11. Clinical trials and tribulations. Cholesterol veers off script.
Couzin J
Science; 2008 Oct; 322(5899):220-3. PubMed ID: 18845747
[No Abstract] [Full Text] [Related]
12. Goals for cholesterol lowering.
Stankler L
Circulation; 1999 May; 99(18):2477. PubMed ID: 10318741
[No Abstract] [Full Text] [Related]
13. [The TNT debate gives a lift to the debate about high-dose statins. Lower LDL cholesterol levels further reduce the cardiovascular risk].
Olsson AG
Lakartidningen; 2005 May 2-15; 102(18-19):1393-4. PubMed ID: 15929421
[No Abstract] [Full Text] [Related]
14. [Lower LDL and/or raise HDL. In what direction is lipidology moving?].
Parhofer KG
MMW Fortschr Med; 2007 May; 149(22):27. PubMed ID: 18069222
[No Abstract] [Full Text] [Related]
15. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.
Gotto AM; Farmer JA
Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):664-72. PubMed ID: 17122799
[TBL] [Abstract][Full Text] [Related]
16. Nicotinic acid: new/old drug. Immediate or sustained release: too risky for a drug with no proven benefit.
Prescrire Int; 2006 Dec; 15(86):213-6. PubMed ID: 17165243
[TBL] [Abstract][Full Text] [Related]
17. [Can cardiovascular events be prevented by raising HDL cholesterol?].
Langslet G; Reikvam A
Tidsskr Nor Laegeforen; 2008 Jun; 128(13):1519-23. PubMed ID: 18587459
[TBL] [Abstract][Full Text] [Related]
18. [Better with lower LDL cholesterol! Aim at 2 mmol/l for secondary prevention].
Olsson AG
Lakartidningen; 2006 Jan 11-17; 103(1-2):22-3. PubMed ID: 16465841
[No Abstract] [Full Text] [Related]
19. Modification of coronary atherosclerosis.
Druck MN
Can J Cardiol; 1993 Mar; 9(2):162-4. PubMed ID: 8490786
[No Abstract] [Full Text] [Related]
20. [Ezetimib--the first selective cholesterol resorption inhibitors. Strengthening of statins].
MMW Fortschr Med; 2002 Nov; 144(48):52-3. PubMed ID: 12532546
[No Abstract] [Full Text] [Related]
[Next] [New Search]